Evidence map›Paper›PMID 41141503›Full record

ArticleKidney international reports2025

Corrigendum to "The Role of Mitochondrial AKT1 Signaling in Renal Tubular Injury of Metabolic Syndrome" [

Hugo Y-H Lin, I-Ya Chen, Tzu-Ming Wang, Chia-Hung Yen, Yumay Chen, Yen-Hua Chen, Dao-Fu Dai, Jee-Fu Huang, Yi-Wen Chiu, Ming-Yu Yang and 1 more

Abstract readPublished Erratum
In one paragraph

Article in Kidney international reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Hugo Y-H LinDivision of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
I-Ya ChenGraduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Tzu-Ming WangDepartment of Medical Research, China Medical University Hospital, Taichung, Taiwan.
Chia-Hung YenGraduate Institute of Natural Product, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yumay ChenSchool of Medicine, University of California, Irvine, California, USA.
Yen-Hua ChenSchool of Medicine, Doctoral Program of Clinical and Experimental Medicine, Institute of Biomedical Sciences, College of Medicine, National Sun Yat-Sen University, Kaohsiung, Taiwan.
Dao-Fu DaiDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Jee-Fu HuangHepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yi-Wen ChiuDivision of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Ming-Yu YangGraduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Chang-Shen LinGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1016/j.ekir.2024.12.021.].

Identifiers

PMID41141503
PMCPMC12545646

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.